Clinical trial · Observational
Childhood Cancer Survivors' Knowledge of Diagnosis,Treatment and Risk of Late Effects: Specialized Survivorship Clinic
Childhood Cancer Survivors' Knowledge of Their Diagnosis, Treatment, and Risk of Late Effects: The Impact of Care in a Specialized Survivorship Clinic
NCT01223872CI-TRIAL-00026744completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This two-part research study will compare childhood cancer survivors receiving specialized follow-up care in the REACH for Survivorship clinic to patients receiving routine follow-up care.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Childhood Cancer | Childhood Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| clinic visit and interview | Other | — | UNRESOLVED |
| interview | Other | — | UNRESOLVED |
| interviews and clinic visit | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Routine Patient Care
- interventionNames
- Other: interview
- label
- Previously-enrolled REACH Clinic Patients
- interventionNames
- Other: clinic visit and interview
- label
- New REACH Clinic Patients
- interventionNames
- Other: interviews and clinic visit
Primary outcomes (1)
- measure
- Knowledge gained by attending a multispecialty Survivorship Clinic which will be measured by comparison of self report with medical record data in both cross-sectional and longitudinal approach.
- timeFrame
- 12 months
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Maximum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * Treatment for primary malignancy per risk-adapted protocol * Age ≤ 21 years at time of diagnosis * Currently alive without evidence of disease * Off therapy for no more than 15 years Exclusion Criteria: -Patients who have received a bone marrow transplant
References
Publications (0)
Data not yet available
No reference posted for this study.